Organizing human specimen collections: Getting the best out of biobanks

The diversity of biobanks, collections of human specimens from a variety of sources, raises questions about the best way to manage and govern them, finds a study published in BioMed Central's open access journal Genome Medicine. The research highlights difficulties in standardizing these collections and how to make these samples available for research.

Biobanks have been around for decades, storing hundreds of millions of human specimens. But there has been a dramatic increase in the number of biobanks in the last ten years, since the human genome sequencing project. Because there is no central registry of biobanks in the US, researchers from the University of North Carolina at Chapel Hill invited over 600 biobanks to participate in an .

The study finds great diversity in when and why these biobanks were created, how they are organized, who pays for them, and what specimens they store. Over half were set up to facilitate research into a particular disease, mainly cancer, but others were created as a 'home' for older sample collections. The number of samples within each is hugely variable, from tens to millions, and can include clinical, pediatric or post-mortem samples, or from research, with origins as varied as blood and solid tissues, or hair and toe nails.

Talking about attempts to put into place policies to regulate biobanks, Prof Gail Henderson, who led this project explained, "Biobanks are part of an emerging and rapidly evolving industry, with an increasingly central role in . Because they have developed in different contexts with different goals and funding sources, any attempt to control or standardize biobanks will need to take into account their organizational diversity and their individual practices and challenges. It is unlikely that a one-size policy will fit all."

More information: Characterizing biobank organizations in the U.S.: results from a national survey Gail E Henderson, R Jean Cadigan, Teresa P Edwards, Ian Conlon, Anders G Nelson, James P Evans, Arlene M Davis, Catherine Zimmer and Bryan J Weiner Genome Medicine, (in press)

add to favorites email to friend print save as pdf

Related Stories

Europe tackles ethics of biobanks

Jun 20, 2012

Collections of human biological samples used in medical research should be governed by clear rules that safeguard ethics while advancing knowledge, scientists said Wednesday at a Council of Europe symposium.

Public prefers limited informed consent process for biobanks

Jun 29, 2011

Biobanks are repositories for tissue samples, usually in the form of blood or saliva or leftover tissue from surgical procedures. These samples are collected and used for future research, including genetic research. They ...

Keeping DNA 'all in the family'

Oct 06, 2009

Scientists look for clues about therapies and cures for life-threatening childhood illnesses in children's DNA -- it seems only logical to do so. But the decision as to who should have access to DNA samples from children ...

Recommended for you

Mysterious esophagus disease is autoimmune after all

7 hours ago

(Medical Xpress)—Achalasia is a rare disease – it affects 1 in 100,000 people – characterized by a loss of nerve cells in the esophageal wall. While its cause remains unknown, a new study by a team of researchers at ...

Diagnostic criteria for Christianson Syndrome

Jul 21, 2014

Because the severe autism-like condition Christianson Syndrome was only first reported in 1999 and some symptoms take more than a decade to appear, families and doctors urgently need fundamental information ...

New technique maps life's effects on our DNA

Jul 20, 2014

Researchers at the BBSRC-funded Babraham Institute, in collaboration with the Wellcome Trust Sanger Institute Single Cell Genomics Centre, have developed a powerful new single-cell technique to help investigate how the environment ...

User comments